Laboratory analysis
From research to diagnosis: the laboratory where quality and reliability merge.
Anti–Cathepsin G Antibodies
Test for the determination of human antibodies of the immunoglobulin class G against cathepsin G, to support the identification and differentiation of ANCA patterns in ANCA-associated systemic vasculitides (AAV), primary sclerosing cholangitis and chronic inflammatory bowel diseases.
Anti-granular protein 100 (sp100) antibodies
Test for the determination of human antibodies of the immunoglobulin class IgG against granular protein 100 (sp100), to support the diagnosis of autoimmune liver diseases, and specifically primary biliary cholangitis (PBC).
Anti-promyelocytic leukaemia protein (PML) antibodies
Test for the determination of human antibodies of the immunoglobulin class IgG against promyelocytic leukaemia protein (PML), to support the diagnosis of autoimmune liver diseases, and specifically primary biliary cholangitis (PBC).
Anti-D-3-phosphoglycerate dehydrogenase (PGDH) antibodies
Test for the determination of human antibodies of the immunoglobulin class IgG the protein against D-3-phosphoglycerate dehydrogenase (PGDH), to support the diagnosis of autoimmune liver diseases, and specifically autoimmune hepatitis (AIH).
Anti-glycoprotein 210 (gp210) antibodies
Test for the determination of human antibodies of the immunoglobulin class IgG against the protein gp210, to support the diagnosis of autoimmune liver diseases, and specifically primary biliary cholangitis (PBC).
Anti-Neutrophil Cytoplasmic Antibodies (ANCA)
Test for the determination of human autoantibodies against anti-neutrophil cytoplasmic antigens in the diagnosis of ANCA-associated vasculitis and certain non-vasculitic diseases.
Anti-acetylcholine receptor (AChR) antibodies
This test detects human antibodies of the immunoglobulin class G against the acetylcholine receptor (AChR), to support the diagnosis of myasthenia gravis.
laboratory
From research to diagnosis: the laboratory where quality and reliability merge.
Discover what’s new
Subscribe to the newsletter
Subscribe to our newsletter to be always updated.